6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
Just now	Paratus Energy: Invitation to Q1 2026 Earnings Call
1m ago	374Water Provides Conference Update and Reaffirms Tailwinds
1m ago	New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System
2m ago	Edible Garden Starts Shipping New Fresh-Cut Herb Program with Target

About

154.67USD+0.31 +0.20%

Closed • Updated at 13:12 GMT+00:00

Market Cap$15.55B

P/E Ratio23.78

Volume1.17M

Beta0.74

RSI66.86

Gross Margin98.17%

Health TechnologyBiotechnology

Neurocrine Biosciences, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics

Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia

Neurocrine Biosciences Reports First-Quarter 2026 Financial Results

Neurocrine Biosciences to Present at the Bank of America Health Care Conference 2026

Community Chat

Ask AI